Clinical significance of STING expression and methylation in lung adenocarcinoma based on bioinformatics analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical significance of STING expression and methylation in lung adenocarcinoma based on bioinformatics analysis
Authors
Keywords
-
Journal
Scientific Reports
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-17
DOI
10.1038/s41598-022-18278-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of STING expression is prognostic in non–small cell lung cancer
- (2022) Zoltan Lohinai et al. JOURNAL OF SURGICAL ONCOLOGY
- Increased activation of cGAS‐STING pathway enhances radiosensitivity of non‐small cell lung cancer cells
- (2022) Aiying Xue et al. Thoracic Cancer
- LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non‐small cell lung cancer
- (2022) Yanping Gao et al. Clinical and Translational Medicine
- cGAS-STING pathway expression as a prognostic tool in NSCLC
- (2021) Kristine Raaby Gammelgaard et al. Translational Lung Cancer Research
- RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma
- (2021) Xueping Jiang et al. Cell and Bioscience
- Navigating the DNA methylation landscape of cancer
- (2021) Atsuya Nishiyama et al. TRENDS IN GENETICS
- MET amplification attenuates lung tumor response to immunotherapy by inhibiting STING
- (2021) Yong Zhang et al. Cancer Discovery
- DNA methylation in lung cancer patients: Opening a "window of life" under precision medicine
- (2021) Runzhang Liang et al. BIOMEDICINE & PHARMACOTHERAPY
- EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion
- (2021) Antonio Marzio et al. CELL
- Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer
- (2021) Xuewei Yan et al. International Journal of Biological Sciences
- STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype
- (2020) Carminia M. Della Corte et al. Journal of Thoracic Oncology
- Genomic landscape of lung adenocarcinoma in East Asians
- (2020) Jianbin Chen et al. NATURE GENETICS
- LncRNA NEAT1 Interacted With DNMT1 to Regulate Malignant Phenotype of Cancer Cell and Cytotoxic T Cell Infiltration via Epigenetic Inhibition of p53, cGAS, and STING in Lung Cancer
- (2020) Fang Ma et al. Frontiers in Genetics
- Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity
- (2020) Henrique Lemos et al. Journal for ImmunoTherapy of Cancer
- A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I–III colon cancer
- (2019) Rui Zhou et al. EBioMedicine
- Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer
- (2019) Triparna Sen et al. Cancer Discovery
- STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade
- (2019) Hannah Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma
- (2019) Katey S. S. Enfield et al. Nature Communications
- Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers
- (2019) Fengju Chen et al. Nature Communications
- Delicate regulation of the cGAS–MITA-mediated innate immune response
- (2018) Wei-Wei Luo et al. Cellular & Molecular Immunology
- Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production
- (2018) Hiroyasu Konno et al. ONCOGENE
- cGAS–STING and Cancer: Dichotomous Roles in Tumor Immunity and Development
- (2018) Kevin W. Ng et al. TRENDS IN IMMUNOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer
- (2018) Shunsuke Kitajima et al. Cancer Discovery
- An Analysis of the Expression and Association with Immune Cell Infiltration of the cGAS/STING Pathway in Pan-Cancer
- (2018) Xiang An et al. Molecular Therapy-Nucleic Acids
- Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
- (2018) Luis M. Seijo et al. Journal of Thoracic Oncology
- STING-mediated DNA sensing in cancer immunotherapy
- (2017) Xiang Zhou et al. Science China-Life Sciences
- Decreased expression of STING predicts poor prognosis in patients with gastric cancer
- (2017) Shushu Song et al. Scientific Reports
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation
- (2016) Henrique Lemos et al. CANCER RESEARCH
- The cGAS-STING Defense Pathway and Its Counteraction by Viruses
- (2016) Zhe Ma et al. Cell Host & Microbe
- Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum
- (2016) Alicia Hulbert et al. CLINICAL CANCER RESEARCH
- Novel therapeutic targets on the horizon for lung cancer
- (2016) Wan-Ling Tan et al. LANCET ONCOLOGY
- Decreased Expression of TMEM173 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
- (2016) Yang Bu et al. PLoS One
- MERAV: a tool for comparing gene expression across human tissues and cell types
- (2015) Yoav D. Shaul et al. NUCLEIC ACIDS RESEARCH
- Diverse roles of STING-dependent signaling on the development of cancer
- (2015) J Ahn et al. ONCOGENE
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Protective role of STING against gliomagenesis: Rational use of STING agonist in anti-glioma immunotherapy
- (2015) Takayuki Ohkuri et al. OncoImmunology
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
- (2014) Liufu Deng et al. IMMUNITY
- Cutting Edge: STING Mediates Protection against Colorectal Tumorigenesis by Governing the Magnitude of Intestinal Inflammation
- (2014) Qifan Zhu et al. JOURNAL OF IMMUNOLOGY
- STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment
- (2014) T. Ohkuri et al. Cancer Immunology Research
- The Genotype-Tissue Expression (GTEx) project
- (2013) John Lonsdale et al. NATURE GENETICS
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- (2013) Balázs Győrffy et al. PLoS One
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
- (2011) Christoph Kneip et al. Journal of Thoracic Oncology
- Adenosquamous lung carcinomas: A histologic subtype with poor prognosis
- (2011) Pier Luigi Filosso et al. LUNG CANCER
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
- (2008) Hiroki Ishikawa et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started